These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31202286)

  • 1. Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection.
    Williams N; Bossert N; Chen Y; Jaanimägi U; Markatou M; Talal AH
    J Subst Abuse Treat; 2019 Jul; 102():33-39. PubMed ID: 31202286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone.
    Talal AH; Andrews P; Mcleod A; Chen Y; Sylvester C; Markatou M; Brown LS
    Clin Infect Dis; 2019 Jul; 69(2):323-331. PubMed ID: 30329042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
    Brown JL; Gause NK; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short communication: Relationship between social determinants and opioid use disorder treatment outcomes by gender.
    Parlier-Ahmad AB; Radic M; Svikis DS; Martin CE
    Drug Alcohol Depend; 2022 Mar; 232():109337. PubMed ID: 35123364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.
    Nolan S; Dias Lima V; Fairbairn N; Kerr T; Montaner J; Grebely J; Wood E
    Addiction; 2014 Dec; 109(12):2053-9. PubMed ID: 25041346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
    Carey KJ; Huang W; Linas BP; Tsui JI
    J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C in a Mobile Low-Threshold Methadone Program.
    Silva MJ; Pereira C; Loureiro R; Balsa C; Lopes P; Água-Doce I; Belo E; Martins HC; Coutinho R; Pádua E
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):657-662. PubMed ID: 28151750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Reaction to Telemedicine for Clinical Management of Hepatitis C Virus Integrated into an Opioid Treatment Program.
    Talal AH; McLeod A; Andrews P; Nieves-McGrath H; Chen Y; Reynolds A; Sylvester C; Dickerson SS; Markatou M; Brown LS
    Telemed J E Health; 2019 Sep; 25(9):791-801. PubMed ID: 30325701
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
    Jordan AE; Cleland CM; Schackman BR; Wyka K; Perlman DC; Nash D
    J Infect Dis; 2020 Sep; 222(Suppl 5):S335-S345. PubMed ID: 32877560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
    Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
    Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
    Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
    JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study.
    Roncero C; Fuster D; Palma-Álvarez RF; Rodriguez-Cintas L; Martinez-Luna N; Álvarez FJ
    AIDS Care; 2017 Dec; 29(12):1551-1556. PubMed ID: 28393548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California.
    Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J
    Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social determinants of health associated with hepatitis C co-infection among people living with HIV: results from the Positive Spaces, Healthy Places study.
    Rourke SB; Sobota M; Tucker R; Bekele T; Gibson K; Greene S; Price C; Koornstra JJ; Monette L; Byers S; Watson J; Hwang SW; Guenter D; Dunn J; Ahluwalia A; Wilson MG; Bacon J;
    Open Med; 2011; 5(3):e120-31. PubMed ID: 22046224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.
    Martinez AD; Dimova R; Marks KM; Beeder AB; Zeremski M; Kreek MJ; Talal AH
    J Viral Hepat; 2012 Jan; 19(1):47-54. PubMed ID: 21129131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
    Jordan AE; Cleland CM; Wyka K; Schackman BR; Perlman DC; Nash D
    J Infect Dis; 2020 Sep; 222(Suppl 5):S322-S334. PubMed ID: 32877567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program.
    Felsen UR; Fishbein DA; Litwin AH
    J Addict Dis; 2010 Oct; 29(4):461-5. PubMed ID: 20924882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.
    Talal AH; Dimova RB; Seewald R; Peterson RH; Zeremski M; Perlman DC; Des Jarlais DC
    J Subst Abuse Treat; 2013 Jan; 44(1):115-9. PubMed ID: 22405884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study.
    Krans EE; Zickmund SL; Rustgi VK; Park SY; Dunn SL; Schwarz EB
    Subst Abus; 2016; 37(1):88-95. PubMed ID: 26569631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.